明德生物 (002932)

Wuhan Easy Diagnosis Biomedicine Co.,Ltd.

ASZ

Tags

DeepSeekSpecialized-Sophisticated-Distinctive-Innovative EnterprisesLow Price-to-Book RatioVenture Capital ConceptPharmaceutical ManufacturingGene ConceptNon-GAAP LossesSmart HealthcareBelow Net Asset ValueHepatitis ConceptMargin Trading and Securities LendingAssisted ReproductionRestructuring ProposalsHigh Price-to-Earnings RatioHigh-Dividend Yield Stocks

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 23252.10
  • Circulating A-Shares(W): 15608.52
  • Earnings Per Share(RMB): 0.0616
  • Net Assets Per Share(RMB): 23.9167
  • Operating Revenue(W RMB): 22680.82
  • Total Profit(W RMB): -527.80
  • Net Profit Attributable to Parent(W RMB): 1351.55
  • Net Profit Growth Rate(%): -83.30
  • Weighted Return on Equity(%): 0.2400
  • Operating Cash Flow Per Share(RMB): -0.3800
  • Undistributed Profit Per Share(RMB): 17.7522
  • Capital Reserve Per Share(RMB): 3.5184

2. Main Business

The main business covers:

  • Research, development, production, sales and service of in vitro diagnostic reagents and diagnostic instruments

3. Company Basic Information

  • Company Name: Wuhan Easy Diagnosis Biomedicine Co., Ltd.
  • Listing Date: 2018-07-10
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 77 Jiulong Middle Road, East Lake New Technology Development Zone, Wuhan City, Hubei Province
  • Website: www.mdeasydiagnosis.com
  • Company Profile: The company was established by the overall change of Mingde Co., Ltd. into a joint stock company. Based on the audited net assets of 9,646,112.83 yuan as of August 31, 2013, Mingde Co., Ltd. was converted into 6 million shares at a ratio of 1.6077:1 and transformed into a joint stock company. On November 13, 2013, the company obtained the "Business License of Enterprise Legal Person" with registration number 420100000053229 from the Wuhan Administration for Industry and Commerce.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 GF Value Core Hybrid Securities Investment Fund A Class Fund 284.62 1.82
2 Rongtong China Wind No.1 Flexible Allocation Hybrid Securities Investment Fund A Class Fund 230.06 1.47
3 E Fund CSI Dividend Tradable Open-End Index Securities Investment Fund Fund 228.09 1.46
4 Rongtong Health Industry Flexible Allocation Hybrid Securities Investment Fund A Class Fund 220.06 1.41
5 China Merchants CSI Dividend Tradable Open-End Index Securities Investment Fund Fund 189.63 1.21
6 Xinyuan Specialized, Sophisticated, Distinctive and New Enterprise Selection Theme Hybrid Securities Investment Fund A Class Fund 35.37 0.23

5. Concept Sectors

  • Venture Capital Concept
  • Gene Concept
  • Intelligent Healthcare
  • Assisted Reproduction
  • Hepatitis Concept
  • DeepSeek
  • Margin Trading
  • Low Price-to-Book Ratio
  • High Price-to-Earnings Ratio
  • Below Net Asset Value
  • High Dividend Stocks
  • Non-Recurring Loss
  • Restructuring Plan
  • Specialized, Sophisticated, Distinctive and New
  • Yesterday's Strong Performer
  • Yesterday's Sudden Surge

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information